
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
Jernej Pušnik, Jasmin Zorn, Werner O. Monzon-Posadas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Jernej Pušnik, Jasmin Zorn, Werner O. Monzon-Posadas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression
Bing-Yi Pan, IShin Tseng, Yen‐Chen Anne Feng, et al.
Journal of the Formosan Medical Association (2025)
Open Access | Times Cited: 1
Bing-Yi Pan, IShin Tseng, Yen‐Chen Anne Feng, et al.
Journal of the Formosan Medical Association (2025)
Open Access | Times Cited: 1
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 5
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 5
The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response
Franz Mai, Emil C. Reisinger, Brigitte Müller‐Hilke
Clinical Immunology (2025) Vol. 278, pp. 110523-110523
Open Access
Franz Mai, Emil C. Reisinger, Brigitte Müller‐Hilke
Clinical Immunology (2025) Vol. 278, pp. 110523-110523
Open Access
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies
Lei You, Luning Zhang, Shengqun Ouyang, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access
Lei You, Luning Zhang, Shengqun Ouyang, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access
Vaccination against rapidly evolving pathogens and the entanglements of memory
Sarah Cobey
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2015-2023
Closed Access | Times Cited: 3
Sarah Cobey
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2015-2023
Closed Access | Times Cited: 3
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity
Jernej Pušnik, Werner O. Monzon-Posadas, Emmanuil Osypchuk, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Jernej Pušnik, Werner O. Monzon-Posadas, Emmanuil Osypchuk, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Computational Modeling of Transformations of Epidemic Waves of BA.2.86/JN.1 SAR-COV-2 Coronavirus Variants on the Basis of Hybrid Oscillators
A. Yu. Perevaryukha
Technical Physics (2024)
Closed Access | Times Cited: 2
A. Yu. Perevaryukha
Technical Physics (2024)
Closed Access | Times Cited: 2
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access | Times Cited: 2
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access | Times Cited: 2
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
Journal of Infection (2024), pp. 106402-106402
Open Access | Times Cited: 1
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
Journal of Infection (2024), pp. 106402-106402
Open Access | Times Cited: 1
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access
Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting
Jeffrey Seow, George Jefferson, Michael D. Keegan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012724-e1012724
Open Access
Jeffrey Seow, George Jefferson, Michael D. Keegan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012724-e1012724
Open Access